Erectile dysfunction in a male human patient is ameliorated by oral administration to the patient of a phosphodiesterase type 5 (PDE5) inhibitor, such as sildenafil, vardenafil, or tadalafil, and a glucocorticoid such as prednisone, prednisolone, cortisone, hydrocortisone, or methylprednisolone.